Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
Clinical trial NCT00348309 · COMPLETED
Trial details
- NCT number
- NCT00348309
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-06
- Primary completion
- 2009-01-01
- Enrollment
- 1496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.